Doyle Thomas James

EDGAR CIK 0001910331

Kura Oncology, Inc. - KURA

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Officer
SVP, Finance & Accounting
Direct Buys
0
$0
0 Shares
Direct Sells
1
($41,262)
-2,318 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/29/2024
01/31/2024
Sell
-2,318 @ $17.80
 ($41,262) 48,093 (-4.60%) Direct